Treatment of relapsed B-cell non-Hodgkin's lymphoma with a combination of chimeric anti-CD20 monoclonal antibodies (rituximab) and G-CSF: final report on safety and efficacy. [electronic resource]
Producer: 20031106Description: 1658-64 p. digitalISSN:- 0887-6924
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Dose-Response Relationship, Drug
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Lactoferrin -- blood
- Leukocyte Elastase -- blood
- Lymphoma, B-Cell -- drug therapy
- Middle Aged
- Neutrophil Activation -- drug effects
- Recurrence
- Remission Induction
- Rituximab
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.